Naturhouse Health, S.A. (BME:NTH)
Spain
· Delayed Price · Currency is EUR 1.730
-0.020 (-1.14%)
Apr 24, 2025, 5:35 PM CET
Naturhouse Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 49.43 | 50.41 | 52.4 | 57.59 | 55.08 | Upgrade
|
| Revenue Growth (YoY) | -1.95% | -3.81% | -9.01% | 4.56% | -32.55% | Upgrade
|
| Cost of Revenue | 14.15 | 13.9 | 15.16 | 16.58 | 16.11 | Upgrade
|
| Gross Profit | 35.28 | 36.51 | 37.24 | 41.01 | 38.97 | Upgrade
|
| Selling, General & Admin | 13.87 | 12.6 | 14.62 | 14.97 | 16.25 | Upgrade
|
| Other Operating Expenses | 6.32 | 5.37 | 7.48 | 6.05 | 5.09 | Upgrade
|
| Operating Expenses | 22.14 | 20.23 | 24.4 | 23.47 | 24.6 | Upgrade
|
| Operating Income | 13.14 | 16.28 | 12.84 | 17.54 | 14.37 | Upgrade
|
| Interest Expense | -0.6 | -0.62 | -0.21 | -0.1 | -0.19 | Upgrade
|
| Interest & Investment Income | 0.54 | 0.04 | 0.11 | 0.36 | 0.02 | Upgrade
|
| Earnings From Equity Investments | 0.47 | -0.15 | 0.31 | 0.59 | 0.3 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.13 | 0.04 | 0.06 | 0.15 | Upgrade
|
| EBT Excluding Unusual Items | 13.53 | 15.43 | 13.09 | 18.45 | 14.66 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | -0.01 | 0.01 | -0.21 | -1.15 | Upgrade
|
| Pretax Income | 13.54 | 15.42 | 13.1 | 18.25 | 13.51 | Upgrade
|
| Income Tax Expense | 3.68 | 4.17 | 3.48 | 4.88 | 4.13 | Upgrade
|
| Earnings From Continuing Operations | 9.86 | 11.25 | 9.62 | 13.37 | 9.39 | Upgrade
|
| Minority Interest in Earnings | - | 0.05 | 0.01 | -0.01 | -0.01 | Upgrade
|
| Net Income | 9.86 | 11.29 | 9.63 | 13.36 | 9.38 | Upgrade
|
| Net Income to Common | 9.86 | 11.29 | 9.63 | 13.36 | 9.38 | Upgrade
|
| Net Income Growth | -12.66% | 17.30% | -27.95% | 42.46% | -29.25% | Upgrade
|
| Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 60 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 60 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | -0.03% | Upgrade
|
| EPS (Basic) | 0.16 | 0.19 | 0.16 | 0.22 | 0.16 | Upgrade
|
| EPS (Diluted) | 0.16 | 0.19 | 0.16 | 0.22 | 0.16 | Upgrade
|
| EPS Growth | -15.06% | 17.73% | -27.27% | 40.62% | -28.89% | Upgrade
|
| Free Cash Flow | 11.22 | 20.38 | 6.13 | 16.12 | 14.38 | Upgrade
|
| Free Cash Flow Per Share | 0.19 | 0.34 | 0.10 | 0.27 | 0.24 | Upgrade
|
| Dividend Per Share | - | - | 0.150 | 0.200 | 0.060 | Upgrade
|
| Dividend Growth | - | - | -25.00% | 233.33% | -76.00% | Upgrade
|
| Gross Margin | 71.38% | 72.42% | 71.06% | 71.21% | 70.75% | Upgrade
|
| Operating Margin | 26.58% | 32.29% | 24.51% | 30.46% | 26.09% | Upgrade
|
| Profit Margin | 19.96% | 22.40% | 18.37% | 23.20% | 17.03% | Upgrade
|
| Free Cash Flow Margin | 22.70% | 40.43% | 11.70% | 27.99% | 26.11% | Upgrade
|
| EBITDA | 13.52 | 16.83 | 13.37 | 19.86 | 17.47 | Upgrade
|
| EBITDA Margin | 27.36% | 33.39% | 25.52% | 34.48% | 31.72% | Upgrade
|
| D&A For EBITDA | 0.39 | 0.55 | 0.53 | 2.31 | 3.1 | Upgrade
|
| EBIT | 13.14 | 16.28 | 12.84 | 17.54 | 14.37 | Upgrade
|
| EBIT Margin | 26.58% | 32.29% | 24.51% | 30.46% | 26.09% | Upgrade
|
| Effective Tax Rate | 27.17% | 27.04% | 26.59% | 26.74% | 30.54% | Upgrade
|
| Advertising Expenses | 3.38 | 2.67 | 3.5 | 3.93 | 2.87 | Upgrade
|
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.